SEC Tracker
Get the app

Ani Pharmaceuticals ANIP

ANI Pharmaceuticals, Inc. held its 2025 Annual Meeting of Stockholders on May 22, 2025.

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Reports an executive or board change (5.02)
  • Amends its charter or bylaws (5.03)
  • Reports shareholder vote results (5.07)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Ani Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Celldex Therapeutics CLDX public float $1.3B, Jun 30, 2025
  2. Travere Therapeutics TVTX public float $1.3B, Jun 30, 2025
  3. Innoviva INVA public float $1.3B, Jun 30, 2025
  4. Adaptive Biotechnologies ADPT public float $1.4B, Jun 30, 2025
  5. Arrowhead Pharmaceuticals ARWR public float $1.4B, Mar 31, 2025, over 18 months old

Data on this page was fetched . The filing on SEC.gov is the record.